Low-dose of amitriptyline may be safe, tolerable and effective for reducing neck pain, disability, and sleep disturbances in patients with idiopathic or non-traumatic chronic neck pain.
Women who were treated as adolescents with a restrictive Milwaukee brace during adolescence may be at higher risk for experiencing low back pain and neck-related disabilities in adulthood.
Mental disorders are positively associated with subsequent self-reported chronic back and/or neck pain, with a clear dose-response relationship between the number of mental disorders and subsequent pain.
A man with a history of hypertension and migraines complains of a headache he has had for approximately 3 days alongside neck stiffness and a fever.
A 44-year-old man presents to his local urgent care clinic for chest pain radiating up into his neck. He states that the pain started 5 hours ago and is gradually getting worse.
Meta-analysis indicates short-term NSAID use is generally safe and can relieve pain, but lacks clinically important benefits.
Results showed a significant link between serum vitamin C concentrations and the prevalence of low back pain.
The prevalence of neck pain has been reported to be increasing among adolescents, but how this pain might affect head posture and endurance of the neck muscles in this age group has received little attention.
Prevalence of cervical degenerative disc disease tended to be 1.38 times higher in women (4.5%) than in men (3.3%).
Routine screening for psychosocial, physical, and neurophysiologic factors may be indicated.
Acupuncture, 'Alexander Technique' helped more than drugs and physical therapy.
Lidocaine-injection therapy in the intramuscular innervation zone effectively treats neck pain caused by myofascial trigger points.
Improving diagnostic skills can assist clinicians in formulating a differential diagnosis for back and neck pain.
Improvements in pain and dysfunction at 12 weeks for those receiving additional massages.
Certain stressors are more likely to increase the risk of pain.
The FDA has approved an expansion of the Botox (onabotulinumtoxinA; Actavis) label for the treatment of adults with upper limb spasticity.
Research shows that magnets placed on the skin relaxes capillary walls.
Clinical Pain Advisor Articles
- Safety, Efficacy of Lidocaine Infusion for Prolonged Neuropathic Pain
- Assessing the Efficacy of Low-Dose Amitriptyline for Idiopathic Chronic Neck Pain
- CBT vs Pain Education for Chronic Pain in Low-Income Clinics
- Non-Opioid Therapies for Pain Management in the ED
- Trigger Point Dry Needling Plus Exercise Cost-Effective for Subacromial Pain Syndrome
- Exploring the Connections Between Neuropathic Pain and Comorbid Mood Disorders
- Medical Marijuana Laws, Dispensaries May Reduce Deaths From Opioid Overdose
- Ketamine Infusion May Be Effective for the Short-Term Relief of CRPS-Associated Pain
- An Avenue for the Development of Opioid Adjuncts for Enhanced Analgesia, Reduced Abuse Potential
- Spinal Manipulative Therapy May Effectively Reduce Cervicogenic Headache Days
- Chronic Pain in Adolescents and Alexithymia
- Bedside Quantitative Sensory Testing May Reliably Assess Sensory Profiles in Neuropathic Pain
- Peripheral Neuropathy Management in the Primary Care Setting: A Guide
- The Link Between Medical Malpractice and Defensive Medicine
- Drug Copayments Often Exceed Prescription Drug Costs